HIF-2 inhibitor, erythrocytosis, and pulmonary hypertension

Blood. 2021 May 6;137(18):2424-2425. doi: 10.1182/blood.2020010323.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Erythropoietin*
  • Humans
  • Hypertension, Pulmonary* / drug therapy
  • Polycythemia*

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Erythropoietin